Business Description
Onward Medical NV
ISIN : NL0015000HT4
Compare
Compare
Traded in other countries / regions
ONWD.BelgiumONWRF.USA63E.GermanyONWDb.UK IPO Date
2021-10-25Description
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injuries. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United States and four European markets: Germany, France, the UK, and the Netherlands to create a customer base.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.76 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.94 | |||||
Debt-to-EBITDA | -0.5 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 24.3 | |||||
3-Year EPS without NRI Growth Rate | 29.3 | |||||
3-Year FCF Growth Rate | 21.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
6-1 Month Momentum % | 8.13 | |||||
12-1 Month Momentum % | 8.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.7 | |||||
Quick Ratio | 4.7 | |||||
Cash Ratio | 4.46 | |||||
Days Payable | 717.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -72.3 | |||||
Shareholder Yield % | -1.24 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -103.54 | |||||
ROA % | -60.55 | |||||
ROIC % | -257.33 | |||||
ROC (Joel Greenblatt) % | -1647.58 | |||||
ROCE % | -66.4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 8.59 | |||||
Price-to-Tangible-Book | 18.96 | |||||
EV-to-EBIT | -4.72 | |||||
EV-to-EBITDA | -4.82 | |||||
EV-to-FCF | -5.01 | |||||
Price-to-Net-Current-Asset-Value | 26.85 | |||||
Price-to-Net-Cash | 39.24 | |||||
Earnings Yield (Greenblatt) % | -21.19 | |||||
FCF Yield % | -18.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Onward Medical NV Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | 0 | ||
Beta | 0 | ||
Volatility % | 8.13 | ||
14-Day RSI | 100 | ||
14-Day ATR (€) | 0.000017 | ||
20-Day SMA (€) | 6.12 | ||
12-1 Month Momentum % | 8.13 | ||
52-Week Range (€) | 5.66 - 6.12 | ||
Shares Outstanding (Mil) | 34.63 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Onward Medical NV Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Onward Medical NV Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Onward Medical NV Frequently Asked Questions
What is Onward Medical NV(CHIX:ONWDb)'s stock price today?
The current price of CHIX:ONWDb is €6.12. The 52 week high of CHIX:ONWDb is €6.12 and 52 week low is €5.66.
When is next earnings date of Onward Medical NV(CHIX:ONWDb)?
The next earnings date of Onward Medical NV(CHIX:ONWDb) is .
Does Onward Medical NV(CHIX:ONWDb) pay dividends? If so, how much?
Onward Medical NV(CHIX:ONWDb) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |